^Tran YK, Bögler O, Gorse KM, Wieland I, Green MR, Newsham IF (Jan 1999). "A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer". Cancer Research. 59 (1): 35–43.
PMID9892180.
^
abEwing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007).
"Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology. 3 (1): 89.
doi:
10.1038/msb4100134.
PMC1847948.
PMID17353931.
^Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research. 62 (18): 5129–33.
PMID12234973.
Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (Jun 2000). "Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas". Human Molecular Genetics. 9 (10): 1495–500.
doi:
10.1093/hmg/9.10.1495.
PMID10888600.
Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research. 62 (18): 5129–33.
PMID12234973.
Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M (Feb 2003). "Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms". International Journal of Cancer. 103 (4): 483–8.
doi:
10.1002/ijc.10840.
PMID12478663.
S2CID39741503.
Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, Ohara O, Carnaud M, Girault JA (Jan 2003). "Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres". The European Journal of Neuroscience. 17 (2): 411–6.
doi:
10.1046/j.1460-9568.2003.02441.x.
PMID12542678.
S2CID21570541.
Robb VA, Li W, Gutmann DH (Apr 2004). "Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression". Oncogene. 23 (20): 3589–96.
doi:
10.1038/sj.onc.1207445.
PMID15116094.
S2CID25066198.
Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF (Jul 2004). "Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation". Genes, Chromosomes & Cancer. 40 (3): 190–203.
doi:
10.1002/gcc.20034.
PMID15138999.
S2CID39309236.
^Tran YK, Bögler O, Gorse KM, Wieland I, Green MR, Newsham IF (Jan 1999). "A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer". Cancer Research. 59 (1): 35–43.
PMID9892180.
^
abEwing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007).
"Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology. 3 (1): 89.
doi:
10.1038/msb4100134.
PMC1847948.
PMID17353931.
^Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research. 62 (18): 5129–33.
PMID12234973.
Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (Jun 2000). "Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas". Human Molecular Genetics. 9 (10): 1495–500.
doi:
10.1093/hmg/9.10.1495.
PMID10888600.
Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya M, Murakami Y (Sep 2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Research. 62 (18): 5129–33.
PMID12234973.
Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M (Feb 2003). "Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms". International Journal of Cancer. 103 (4): 483–8.
doi:
10.1002/ijc.10840.
PMID12478663.
S2CID39741503.
Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, Ohara O, Carnaud M, Girault JA (Jan 2003). "Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres". The European Journal of Neuroscience. 17 (2): 411–6.
doi:
10.1046/j.1460-9568.2003.02441.x.
PMID12542678.
S2CID21570541.
Robb VA, Li W, Gutmann DH (Apr 2004). "Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression". Oncogene. 23 (20): 3589–96.
doi:
10.1038/sj.onc.1207445.
PMID15116094.
S2CID25066198.
Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF (Jul 2004). "Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation". Genes, Chromosomes & Cancer. 40 (3): 190–203.
doi:
10.1002/gcc.20034.
PMID15138999.
S2CID39309236.